Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracervical Vasopressin for Completion of Hysteroscopic Removal of Retained Products of Conception

NCT07102615 is registered in ClinicalTrials.gov with Prisma Health-Upstate as lead sponsor.

NCT NCT07102615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07102615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracervical Vasopressin for Completion of Hysteroscopic Removal of Retained Products of Conception
Lead sponsor
Prisma Health-Upstate
Phase
Phase 4
Overall status
Recruiting
Start date
October 30, 2025
Completion date
December 1, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retained products of conception